SCM
IONS icon

Sterling Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

Sterling Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$102K Sell
1,289
-136
-10% -$10.2K ﹤0.01% 1391
2026
Q1 		$107K Sell
1,425
-288
-17% -$22.7K ﹤0.01% 1374
2025
Q4 		$136K Buy
1,713
+815
+91% +$61.4K ﹤0.01% 1424
2025
Q3 		$58.7K Sell
898
-64
-7% -$3.13K ﹤0.01% 1708
2025
Q2 		$38K Sell
962
-139
-13% -$4.55K ﹤0.01% 1575
2025
Q1 		$33.2K Sell
1,101
-1,909
-63% -$62.5K ﹤0.01% 1527
2024
Q4 		$105K Sell
3,010
-35
-1% -$1.31K ﹤0.01% 1428
2024
Q3 		$122K Buy
+3,045
New +$142K ﹤0.01% 1364
2015
Q1 		– Sell
-32,703
Closed -$2.02M – 914
2014
Q4 		$2.02M Sell
32,703
-29,892
-48% -$1.48M 0.02% 391
2014
Q3 		$2.43M Sell
62,595
-4,075
-6% -$144K 0.03% 308
2014
Q2 		$2.3M Sell
66,670
-16,917
-20% -$533K 0.02% 306
2014
Q1 		$3.61M Sell
83,587
-34,200
-29% -$1.66M 0.03% 206
2013
Q4 		$4.69M Buy
+117,787
New +$4.2M 0.04% 172

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Sterling Capital Management's IONS Position: Q2 2026 in Review

Sterling Capital Management reduced its Ionis Pharmaceuticals (IONS) stake by 9.5% in Q2 2026, selling an estimated $10.2K and leaving 1,289 shares worth $102K. The position accounts for ﹤0.01% of the portfolio, ranked #1391.

Sterling Capital Management first reported a position in IONS in Q4 2013 and has held it in 13 quarters since. The position peaked at $4.69M in Q4 2013. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Sterling Capital Management held 1,289 shares of Ionis Pharmaceuticals worth $102K as of Q2 2026.
  • Sterling Capital Management sold 136 Ionis Pharmaceuticals shares in Q2 2026, an estimated $10.2K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1391 holding.
  • Sterling Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2013 and has held it in 13 quarters since.
  • Sterling Capital Management's Ionis Pharmaceuticals position peaked at $4.69M in Q4 2013.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.